Product Information

KLOR-CON 10 MEQ TABLET is a brand (anda) product labeled by Upsher-Smith Laboratories LLC, priced at $0.1235 per EA under NDC 00245083611. Its NADAC has been published 29 times since Feb 4, 2026.

FDA first approved this application on Oct 28, 2024. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

KLOR-CON 10 MEQ TABLET

potassium chloride
$0.1235per EA

Strength

750 mg/1

NDC

00245083611

Classification

Brand (ANDA)

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA218979

FDA Approved

10/28/2024

TE Code

AB2

On Market Since

8/15/2025

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for KLOR-CON 10 MEQ TABLET has been published 29 times since Feb 4, 2026, and over the history we have for it it has risen 13.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1235 per EA
All-time high$0.1235 (Aug 19, 2026)
All-time low$0.1093 (Feb 4, 2026)
52-week high$0.1235
52-week low$0.1093
Median price$0.1093
Average price$0.1117
Largest weekly change+13.0% (Jul 22, 2026)
Weeks tracked29
Tracking sinceFeb 4, 2026

Price History

1W

0.0%

1M

0.0%

3M

+13.0%

6M

+13.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

+13.0%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of KLOR-CON 10 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for KLOR-CON 10 MEQ TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1235 per EA (NDC 00245083611), effective Aug 19, 2026.

How has the price of KLOR-CON 10 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for KLOR-CON 10 MEQ TABLET has risen 13.0%. It has been tracked across 29 weekly CMS publications since Feb 4, 2026.

What are the highest and lowest recorded NADAC prices for KLOR-CON 10 MEQ TABLET?

Since Feb 4, 2026, the NADAC for KLOR-CON 10 MEQ TABLET has ranged from a low of $0.1093 (Feb 4, 2026) to a high of $0.1235 (Aug 19, 2026), with a median of $0.1093 per EA.

Are there cheaper alternatives to KLOR-CON 10 MEQ TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 10 MEQ TABLET, is $0.0838 per EA — about 32% below KLOR-CON 10 MEQ TABLET.

Who manufactures KLOR-CON 10 MEQ TABLET?

KLOR-CON 10 MEQ TABLET (NDC 00245083611) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand (anda) product.